BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10851568)

  • 1. An acquired factor V inhibitor: clinical and laboratory features.
    Shastri KA; Ho C; Logue G
    J Med; 1999; 30(5-6):357-66. PubMed ID: 10851568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A long-lasting idiopathic factor V inhibitor].
    Okoshi Y; Akiyama H; Inoue T; Koyama T; Kono N; Matsumura T; Mizuchi D; Mori S; Ohashi K; Sakamaki H
    Rinsho Ketsueki; 2003 Jan; 44(1):14-8. PubMed ID: 12649832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency.
    Lim S; Zuha R; Burt T; Chacko J; Scott R; Mainwaring CJ
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):667-71. PubMed ID: 17102654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired circulating anticoagulant with anti-factor V activity in AIDS: first case report.
    Denis A; Baudeau C; Verdy E; Couderc R; Rondeau E; Sraer JD
    Nouv Rev Fr Hematol (1978); 1995; 37(2):165-9. PubMed ID: 7644356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
    Cmolik BL; Spero JA; Magovern GJ; Clark RE
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):222-7; discussion 227-8. PubMed ID: 8429648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
    Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
    J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality therapy of an acquired factor V inhibitor.
    Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
    Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.
    Humphries JE; Acker MN; Pinkston JE; Ruddy S
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):372-6. PubMed ID: 7978060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin].
    Miesbach W; Voigt J; Peetz D; Scharrer I
    Med Klin (Munich); 2003 Jun; 98(6):339-43. PubMed ID: 12811419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired inhibitors of factor V.
    Feinstein DI
    Thromb Haemost; 1978 Jun; 39(3):663-74. PubMed ID: 705695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A spontaneous factor V inhibitor with unexpected laboratory features.
    Brandt JT; Britton A; Kraut E
    Arch Pathol Lab Med; 1986 Mar; 110(3):224-7. PubMed ID: 3753856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma.
    Maughan EO; Wilson J; Wilde JT
    Int J Lab Hematol; 2007 Aug; 29(4):316-9. PubMed ID: 17617083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case positive for the inhibitor for coagulation factor V].
    Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
    Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V inhibitor associated with immune complex formation.
    Lazarchick J; Wolff CM; Pepkowitz SH; Kizer J; Romein LA
    Arch Pathol Lab Med; 1986 May; 110(5):448-51. PubMed ID: 3754431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anesthetic management of a patient with acquired factor V inhibitor].
    Nakamura T; Otsuji M; Kurita A; Yamada K; Tsubokawa T; Yamamoto K
    Masui; 2010 Nov; 59(11):1423-7. PubMed ID: 21077315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.